Viemed Healthcare Stock Performance
| VMD Stock | USD 8.75 0.04 0.46% |
On a scale of 0 to 100, Viemed Healthcare holds a performance score of 11. The entity has a beta of 1.31, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Viemed Healthcare will likely underperform. Please check Viemed Healthcare's total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to make a quick decision on whether Viemed Healthcare's existing price patterns will revert.
Risk-Adjusted Performance
11 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Viemed Healthcare are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain primary indicators, Viemed Healthcare exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.46 | Five Day Return (0.91) | Year To Date Return 9.51 | Ten Year Return 387.85 | All Time Return 387.85 |
1 | Disposition of 6735 shares by William Zehnder of Viemed Healthcare subject to Rule 16b-3 | 09/03/2024 |
2 | 3 Growth Companies With High Insider Ownership In US Growing Revenues At 20 | 09/27/2024 |
3 | VMD Sciences Launches Lifesaving Expanded Access Programs for Veterinary Medicine | 10/02/2024 |
4 | Acquisition by Heltz Sabrina of 10719 shares of Viemed Healthcare subject to Rule 16b-3 | 10/08/2024 |
5 | Viemed Healthcare Inc Q2 2024 Earnings Call Highlights Record Revenue and Strategic ... | 10/09/2024 |
6 | Acquisition by William Zehnder of 6735 shares of Viemed Healthcare subject to Rule 16b-3 | 10/23/2024 |
7 | Viemed Healthcare Set to Announce Earnings on Wednesday | 11/04/2024 |
8 | Viemed Healthcare Announces Third Quarter 2024 Financial Results | 11/06/2024 |
9 | Disposition of 30000 shares by Kaushal Nitin of Viemed Healthcare at 2.5 subject to Rule 16b-3 | 11/11/2024 |
10 | Disposition of 15000 shares by Kaushal Nitin of Viemed Healthcare at 2.5 subject to Rule 16b-3 | 11/19/2024 |
11 | Viemed Healthcare director sells shares worth 255,900 | 11/21/2024 |
| Begin Period Cash Flow | 16.9 M |
Viemed |
Viemed Healthcare Relative Risk vs. Return Landscape
If you would invest 739.00 in Viemed Healthcare on August 27, 2024 and sell it today you would earn a total of 136.00 from holding Viemed Healthcare or generate 18.4% return on investment over 90 days. Viemed Healthcare is generating 0.2842% of daily returns assuming volatility of 2.0204% on return distribution over 90 days investment horizon. In other words, 17% of stocks are less volatile than Viemed, and above 95% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Viemed Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Viemed Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Viemed Healthcare, and traders can use it to determine the average amount a Viemed Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1407
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VMD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.02 actual daily | 17 83% of assets are more volatile |
Expected Return
| 0.28 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average Viemed Healthcare is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Viemed Healthcare by adding it to a well-diversified portfolio.
Viemed Healthcare Fundamentals Growth
Viemed Stock prices reflect investors' perceptions of the future prospects and financial health of Viemed Healthcare, and Viemed Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Viemed Stock performance.
| Return On Equity | 0.0888 | ||||
| Return On Asset | 0.0686 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 336.61 M | ||||
| Shares Outstanding | 38.94 M | ||||
| Price To Earning | 29.88 X | ||||
| Price To Book | 2.73 X | ||||
| Price To Sales | 1.59 X | ||||
| Revenue | 183.01 M | ||||
| Gross Profit | 84.68 M | ||||
| EBITDA | 36.68 M | ||||
| Net Income | 10.24 M | ||||
| Cash And Equivalents | 21.92 M | ||||
| Cash Per Share | 0.57 X | ||||
| Total Debt | 10.32 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 2.34 X | ||||
| Book Value Per Share | 3.21 X | ||||
| Cash Flow From Operations | 45.21 M | ||||
| Earnings Per Share | 0.25 X | ||||
| Market Capitalization | 340.7 M | ||||
| Total Asset | 154.9 M | ||||
| Retained Earnings | 79.5 M | ||||
| Working Capital | 6.24 M | ||||
About Viemed Healthcare Performance
By analyzing Viemed Healthcare's fundamental ratios, stakeholders can gain valuable insights into Viemed Healthcare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Viemed Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Viemed Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 24.05 | 45.17 | |
| Return On Tangible Assets | 0.08 | 0.08 | |
| Return On Capital Employed | 0.12 | 0.11 | |
| Return On Assets | 0.07 | 0.06 | |
| Return On Equity | 0.09 | 0.09 |
Things to note about Viemed Healthcare performance evaluation
Checking the ongoing alerts about Viemed Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Viemed Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Viemed Healthcare has a strong financial position based on the latest SEC filings | |
| About 67.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from investing.com: Viemed Healthcare director sells shares worth 255,900 |
- Analyzing Viemed Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Viemed Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Viemed Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Viemed Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Viemed Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Viemed Healthcare's stock. These opinions can provide insight into Viemed Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Viemed Stock analysis
When running Viemed Healthcare's price analysis, check to measure Viemed Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viemed Healthcare is operating at the current time. Most of Viemed Healthcare's value examination focuses on studying past and present price action to predict the probability of Viemed Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viemed Healthcare's price. Additionally, you may evaluate how the addition of Viemed Healthcare to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |